Skip to content


Rhonda Knudsen is a business operations management professional with more than 25 years of experience in the life science, medical device, and technology sectors. She leads the finance, human resources, and business administration functions for Bonum Therapeutics. She joined Good Therapeutics in 2021 and transitioned to Bonum Therapeutics after the acquisition by Roche in 2022. She previously served in leadership positions at Darwin Molecular, Blue Heron Biotech, Institute for Systems Biology, BD Biosciences, and Olympus. 

Rhonda holds a BA from the University of Montana and an MBA from City University of Seattle.